InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
8
T+90 hit rate
71%
T+90 mean return
-4.5%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Seshadri Vishwas, Chief Executive Officer. Officer active across 1 company, notably Abeona Therapeutics INC.. Aggregated, 28 reports have been recorded. Split: 3 buys · 8 sells. Total volume traded: €1.6m. Activity tracked since 1 June 2021. The latest transaction was disclosed on 9 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations28 total
67,971 shares@ US$6.96370.12% mcap28.4% of flowCommon StockSEC:0001493152-26-032744:0
24,428 sharesCommon StockSEC:0001493152-26-028020:0
31,916 sharesCommon StockSEC:0001493152-26-028020:1
29,985 shares@ US$4.38490.039% mcap15.2% of flowCommon StockSEC:0001493152-26-014418:0
365,422 shares0Common StockSEC:0001493152-26-002887:0
19,274 shares@ US$5.3935Common StockSEC:0001493152-25-016543:0
69,420 shares@ US$5.855719.2% of flowCommon StockSEC:0001641172-25-018606:0
50,676 shares@ US$6.7620.5% of flowCommon StockSEC:0001641172-25-014172:0
885 shares@ US$6.240.7% of flowCommon StockSEC:0001641172-25-013428:0
25,000 shares@ US$4.7814.8% of flowCommon StockSEC:0001641172-25-001922:0
476,435 shares0Common StockSEC:0001493152-25-003463:0
251 shares@ US$6.540.2% of flowCommon StockSEC:0001493152-24-041421:0
18,798 shares@ US$5.8913.3% of flowCommon StockSEC:0001493152-24-038802:0
424,000 shares0Common StockSEC:0001493152-24-026642:0
38,621 shares@ US$4.5221.5% of flowCommon StockSEC:0001493152-24-023124:0
703 shares@ US$4.380.4% of flowCommon StockSEC:0001493152-24-022756:0
10,000 shares@ US$3.204.0% of flowCommon StockSEC:0001493152-24-016853:0
Ideal exit: 20 Jan 2025 (T+270)
20,000 shares@ US$4.3910.9% of flowCommon StockSEC:0001493152-24-005208:0
Ideal exit: 2 Nov 2024 (T+270)
181 shares@ US$4.140.1% of flowCommon StockSEC:0001493152-23-037500:0
13,290 shares@ US$3.9334.7% of flowCommon StockSEC:0001493152-23-034916:0
20,000 shares@ US$4.0754.4% of flowCommon StockSEC:0001493152-23-034741:0
Ideal exit: 23 Jun 2024 (T+270)
336,826 shares0Common StockSEC:0001493152-23-020417:0
827 shares@ US$3.060.3% of flowCommon StockSEC:0001493152-23-020291:0
207 shares@ US$4.300.1% of flowCommon StockSEC:0001493152-22-028650:0
155,200 shares0Common StockSEC:0001493152-22-027279:0
25 of 28 declarations
About Seshadri Vishwas
Vishwas Seshadri is the Chief Executive Officer of ABEONA THERAPEUTICS INC. He leads the company by overseeing operations and developing strategies for research and clinical development. His role is essential in guiding ABEONA in the biopharmaceutical sector.
